<SEC-DOCUMENT>0001193125-20-298749-index.html : 20201120
<SEC-HEADER>0001193125-20-298749.hdr.sgml : 20201120
<ACCEPTANCE-DATETIME>20201120083259
ACCESSION NUMBER:		0001193125-20-298749
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200909
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201120
DATE AS OF CHANGE:		20201120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novus Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		201330530

	BUSINESS ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d79037d8ka.htm
<DESCRIPTION>8-K AMENDMENT NO 1
<TEXT>
Document 1 - file: d79037d8ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d79037dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: d79037dex231.htm

</DOCUMENT>
</SEC-DOCUMENT>